Demonstrates equal efficacy between oral temozolomide and dacarbazine in advanced metastatic melanoma, suggesting a viable oral treatment alternative.
Temozolomide demonstrates efficacy equal to that of DTIC and is an oral alternative for patients with advanced metastatic melanoma.
No takes yet. Share an insight, caveat, or question.
Middleton et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: